Product analysis
Boswellia Extract is aimed at joint comfort, but the preparation does not clearly match the specific extracts associated with symptom benefits. Black pepper is included without a demonstrated additional joint benefit.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality36
Boswellic acids are named, but a specific quality advantage cannot be established for the extract. The leucine and black-pepper preparations remain unspecified.
Ingredient Transparency75
All ingredient amounts are listed, making the quantities easier to check. Only the boswellia preparation has form details, leaving leucine and black pepper less clear.
Value For Money38
Leucine is costly for the amount provided. Value for boswellia and black pepper cannot be established confidently.
Customer Satisfaction68
Customer feedback is very positive, but the number of reviews is small. The limited response makes satisfaction less certain than it would be with broader feedback.
Product Focus57
The blend is focused on joint comfort and related inflammatory processes. Benefits depend on the exact boswellia extract, and broader inflammation relief is uncertain.
- Format
Capsule - Container
- 240 Capsule(s)
- Per serving
- $0.21
- Customer rating
- 4.6 · 36 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Indian Frankincense extract (Boswellic Acid) | 500 mg | |
L-Leucine | 100 mg | |
Black Pepper fruit extract | 7.5 mg |
How this ingredient is rated
Composition and Label Disclosure100
Marker and Preparation Disclosure
Composition and Label Disclosure100
Boswellia Amount and Marker Disclosure
Commercial Price and Usability
How this ingredient is rated
Active Ingredient Quality & Bioavailability70
Isomer Purity and Sourcing
Dose, Safety & Label Transparency40
Muscle Protein Synthesis (MPS) Dosage
Dosage Transparency
Value20
Price per Gram of Active Leucine
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
- Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
- A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
- Oral herbal therapies for treating osteoarthritis.
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.